• Home
  • Drugs Controller General of India

Govt panel recommends EUA to Zydus Cadila’s 3-dose COVID-19 vaccine

Biophore applies to DCGI for emergency-use approval for COVID-19 treatment drug

DCGI approves anti-Covid drug developed by DRDO for emergency use

J&J seeks permission for clinical trial of single-shot COVID-19 vaccine in India

Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment

3 more test positive for COVID-19 UK strain in K’taka: Min Sudhakar

COVID-19 vaccine to cost $3-4 to govt, $6-8 in pvt mkt says Serum Institute

Will take COVID-19 vaccine; safety, efficacy not a concern: Kiran Mazumdar-Shaw

Bharat Biotech seeks emergency use authorisation for indigenously developed COVID-19 vaccine Covaxin

Serum Institute seeks emergency use authorisation for Covishield vaccine in India

Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

Serum Institute rejects charges levelled by vaccine trial participant, threatens to seek damages

Netherlands shows interest in indigenously developed Feluda test

Scientists strike note of caution as ‘Made in India’ vaccine programme gains momentum

Biocon gets DCGI nod for device to treat critical COVID-19 patients

Latest Additions

HC denies anticipatory bail to school chairperson booked for abetting student’s suicide

BJP’s Raghunath Rao Malkapure appointed chairman of the Karnataka Legislative Council

BJP converting ‘textbooks’ into ‘partybooks’: HDK

K’taka govt has taken away our powers: Election Commission tells High Court

WPI inflation at record high of 15.08 pc in April on price rise across all items

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.